Anti-MDA5 antibody positive dermatomyositis complicated by interstitial lung disease with an improved outcome: A case report
MDA5-DM-ILD poses challenges for clinicians due to its diagnostic difficulty, rapid progression and secondary infection risks. Early immunosuppression combined with infection prevention is the key to a successful treatment of this disease.
Authors
- Wensheng Jiang (ORCID: https://orcid.org/0000-0002-5711-0003)
- Xiaoping Yang (ORCID: https://orcid.org/0000-0003-1952-7227)
- Lei Xu (ORCID: https://orcid.org/0000-0002-4095-6539)
- Bin Yin (ORCID: https://orcid.org/0000-0002-5542-3209)
- Yong Wang (ORCID: https://orcid.org/0000-0001-6602-0491)
- Wenqing Jiang (ORCID: https://orcid.org/0000-0003-4955-2503)
- Yongji Liu (ORCID: https://orcid.org/0000-0002-6954-7106)
- Min Xu (ORCID: https://orcid.org/0000-0003-4464-453X)
- Jiang Qian (ORCID: https://orcid.org/0009-0006-2328-6955)
- Xiaowei Chai
Institutions
- Qingdao University (CN)
- Qingdao Mental Health Center (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1097/md.0000000000042536
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00